Cargando…
Growth differentiation factor 15 contributes to cancer-associated fibroblasts-mediated chemo-protection of AML cells
BACKGROUND: Chemo-resistance is still a major obstacle in efforts to overcome acute myeloid leukemia (AML). An emerging concept has proposed that interactions between the bone marrow (BM) microenvironment and leukemia cells reduce the sensitivity of the leukemia cells to chemotherapy. As an importan...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029001/ https://www.ncbi.nlm.nih.gov/pubmed/27643489 http://dx.doi.org/10.1186/s13046-016-0405-0 |
_version_ | 1782454442638966784 |
---|---|
author | Zhai, Yuanmei Zhang, Jing Wang, Hui Lu, Wei Liu, Sihong Yu, Yehua Weng, Wei Ding, Zhiyong Zhu, Qi Shi, Jun |
author_facet | Zhai, Yuanmei Zhang, Jing Wang, Hui Lu, Wei Liu, Sihong Yu, Yehua Weng, Wei Ding, Zhiyong Zhu, Qi Shi, Jun |
author_sort | Zhai, Yuanmei |
collection | PubMed |
description | BACKGROUND: Chemo-resistance is still a major obstacle in efforts to overcome acute myeloid leukemia (AML). An emerging concept has proposed that interactions between the bone marrow (BM) microenvironment and leukemia cells reduce the sensitivity of the leukemia cells to chemotherapy. As an important element of the tumor microenvironment, the cancer-associated fibroblasts (CAFs) are considered to be activated modulators in the chemo-resistance of many solid tumors. But their contribution to AML has yet to be fully understood. Here we report a critical role for CAFs which were thought to be a survival and chemo-protective factor for leukemia cells. METHODS: A retrospective study on the BM biopsies from 63 primary AML patients and 59 normal controls was applied to quantitative analysis the fiber stroma in the BM sections. Then immunohistochemistry on the BM biopsies were used to detect the makers of the CAFs. Their effects on drug resistance of leukemia cells were further to be assessed by co-cultured experiments in vitro. Moreover, the possible mechanisms involved in CAF-mediated chemo-protection of AML cells was investigated by antibody neutralization and siRNA knockdown experiments, with particular emphasis on the role of GDF15. RESULTS: In our study, excessive reticular fibers in the BM led to higher frequency of relapse and mortality in primary AML patients, bringing the inspiration for us to investigate the functional roles of the fiber-devied cells. We declared that the CAF cells which expressed higher levels of FSP1, α-SMA or FAP protein were widely distributed in the marrow of AML. Then in vitro co-cultured tests showed that these CAFs could protect leukemia cell lines (THP-1/K562) from chemotherapy. Interestingly, this effect could be decreased by either treatment with a neutralizing anti-GDF15 antibody or knockdown GDF15 (with siGDF15) in CAFs. Furthermore, we also confirmed that the GDF15(+) cells mainly co-localized with FAP, which was identified as the typical phenotype of CAFs in the BM stroma. CONCLUSIONS: We firstly demonstrate that the functional CAFs are widespread within the BM of AML patients and should be a critical chemo-protective element for AML cells by producing amount of GDF15. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13046-016-0405-0) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5029001 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50290012016-09-22 Growth differentiation factor 15 contributes to cancer-associated fibroblasts-mediated chemo-protection of AML cells Zhai, Yuanmei Zhang, Jing Wang, Hui Lu, Wei Liu, Sihong Yu, Yehua Weng, Wei Ding, Zhiyong Zhu, Qi Shi, Jun J Exp Clin Cancer Res Research BACKGROUND: Chemo-resistance is still a major obstacle in efforts to overcome acute myeloid leukemia (AML). An emerging concept has proposed that interactions between the bone marrow (BM) microenvironment and leukemia cells reduce the sensitivity of the leukemia cells to chemotherapy. As an important element of the tumor microenvironment, the cancer-associated fibroblasts (CAFs) are considered to be activated modulators in the chemo-resistance of many solid tumors. But their contribution to AML has yet to be fully understood. Here we report a critical role for CAFs which were thought to be a survival and chemo-protective factor for leukemia cells. METHODS: A retrospective study on the BM biopsies from 63 primary AML patients and 59 normal controls was applied to quantitative analysis the fiber stroma in the BM sections. Then immunohistochemistry on the BM biopsies were used to detect the makers of the CAFs. Their effects on drug resistance of leukemia cells were further to be assessed by co-cultured experiments in vitro. Moreover, the possible mechanisms involved in CAF-mediated chemo-protection of AML cells was investigated by antibody neutralization and siRNA knockdown experiments, with particular emphasis on the role of GDF15. RESULTS: In our study, excessive reticular fibers in the BM led to higher frequency of relapse and mortality in primary AML patients, bringing the inspiration for us to investigate the functional roles of the fiber-devied cells. We declared that the CAF cells which expressed higher levels of FSP1, α-SMA or FAP protein were widely distributed in the marrow of AML. Then in vitro co-cultured tests showed that these CAFs could protect leukemia cell lines (THP-1/K562) from chemotherapy. Interestingly, this effect could be decreased by either treatment with a neutralizing anti-GDF15 antibody or knockdown GDF15 (with siGDF15) in CAFs. Furthermore, we also confirmed that the GDF15(+) cells mainly co-localized with FAP, which was identified as the typical phenotype of CAFs in the BM stroma. CONCLUSIONS: We firstly demonstrate that the functional CAFs are widespread within the BM of AML patients and should be a critical chemo-protective element for AML cells by producing amount of GDF15. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13046-016-0405-0) contains supplementary material, which is available to authorized users. BioMed Central 2016-09-19 /pmc/articles/PMC5029001/ /pubmed/27643489 http://dx.doi.org/10.1186/s13046-016-0405-0 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Zhai, Yuanmei Zhang, Jing Wang, Hui Lu, Wei Liu, Sihong Yu, Yehua Weng, Wei Ding, Zhiyong Zhu, Qi Shi, Jun Growth differentiation factor 15 contributes to cancer-associated fibroblasts-mediated chemo-protection of AML cells |
title | Growth differentiation factor 15 contributes to cancer-associated fibroblasts-mediated chemo-protection of AML cells |
title_full | Growth differentiation factor 15 contributes to cancer-associated fibroblasts-mediated chemo-protection of AML cells |
title_fullStr | Growth differentiation factor 15 contributes to cancer-associated fibroblasts-mediated chemo-protection of AML cells |
title_full_unstemmed | Growth differentiation factor 15 contributes to cancer-associated fibroblasts-mediated chemo-protection of AML cells |
title_short | Growth differentiation factor 15 contributes to cancer-associated fibroblasts-mediated chemo-protection of AML cells |
title_sort | growth differentiation factor 15 contributes to cancer-associated fibroblasts-mediated chemo-protection of aml cells |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029001/ https://www.ncbi.nlm.nih.gov/pubmed/27643489 http://dx.doi.org/10.1186/s13046-016-0405-0 |
work_keys_str_mv | AT zhaiyuanmei growthdifferentiationfactor15contributestocancerassociatedfibroblastsmediatedchemoprotectionofamlcells AT zhangjing growthdifferentiationfactor15contributestocancerassociatedfibroblastsmediatedchemoprotectionofamlcells AT wanghui growthdifferentiationfactor15contributestocancerassociatedfibroblastsmediatedchemoprotectionofamlcells AT luwei growthdifferentiationfactor15contributestocancerassociatedfibroblastsmediatedchemoprotectionofamlcells AT liusihong growthdifferentiationfactor15contributestocancerassociatedfibroblastsmediatedchemoprotectionofamlcells AT yuyehua growthdifferentiationfactor15contributestocancerassociatedfibroblastsmediatedchemoprotectionofamlcells AT wengwei growthdifferentiationfactor15contributestocancerassociatedfibroblastsmediatedchemoprotectionofamlcells AT dingzhiyong growthdifferentiationfactor15contributestocancerassociatedfibroblastsmediatedchemoprotectionofamlcells AT zhuqi growthdifferentiationfactor15contributestocancerassociatedfibroblastsmediatedchemoprotectionofamlcells AT shijun growthdifferentiationfactor15contributestocancerassociatedfibroblastsmediatedchemoprotectionofamlcells |